DB Biotech

DB Biotech is introducing a new technology for the production of highly specific RABBIT CLONAL antibodies. In vitro cloning technology developed by the company enables the preparation of a pure immunoglobulin fraction corresponding to a single clone of B lymphocytes. The obtained immunoglobulin recognizes one single linear epitope on the antigen molecule; therefore this antibody is comparable quality-wise to its monoclonal analogue. Moreover, the influence of the protein tertiary structure – frequently present in epitopes formed during production of monoclonal antibodies – is eliminated in immunoglobulins corresponding to the clonal antibody. In this case, the produced antibody corresponds strictly to the conserved linear epitope of the antigen molecule.

Website : www.dbbiotech.com